Structure driven compound optimization in targeted protein degradation
Open Access
- 1 December 2020
- journal article
- review article
- Published by Elsevier in Drug Discovery Today: Technologies
- Vol. 37, 73-82
Abstract
No abstract availableKeywords
This publication has 73 references indexed in Scilit:
- The Ubiquitin CodeAnnual Review of Biochemistry, 2012
- Cereblon is a direct protein target for immunomodulatory and antiproliferative activities of lenalidomide and pomalidomideLeukemia, 2012
- Targeting the von Hippel–Lindau E3 Ubiquitin Ligase Using Small Molecules To Disrupt the VHL/HIF-1α InteractionJournal of the American Chemical Society, 2012
- Cereblon expression is required for the antimyeloma activity of lenalidomide and pomalidomideBlood, 2011
- The cullin protein familyGenome Biology, 2011
- Jasmonate perception by inositol-phosphate-potentiated COI1–JAZ co-receptorNature, 2010
- Selective inhibition of BET bromodomainsNature, 2010
- Structural basis for the recognition of hydroxyproline in HIF-1α by pVHLNature, 2002
- THE UBIQUITIN SYSTEMAnnual Review of Biochemistry, 1998
- Novel sulfonamides as potential, systemically active antitumor agentsJournal of Medicinal Chemistry, 1992